Business

The global credit insurance market is anticipated to grow at a considerable CAGR of 7.5% during the forecast period. Credit insurance or trade credit insurance facilitates cross-border commerce and investment by defending export markets and banks against the possibility of a payment default. Today, the majority of all global trade relies on some form of credit insurance or guarantee issued by a bank, insurer, or other financial institution which clearly shows the depth of the market. Credit insurance acts as a catalyst that provides financing to the real economy across the globe.  Get Free Sample link @ https://www.omrglobal.com/request-sample/credit-insurance-market Moreover, by protecting exporters and banks against the risk of non-payment, credit insurance enables cross-border trade and investment which will provide an additional thrust to the market growth. With the rising import and export activities, organizations are widely investing in various financial tools, such ... Continue reading →

The global SaaS-based expense management market is anticipated to grow at a considerable CAGR of 10.5% during the forecast period. SaaS provides more benefits over traditional software licensing models since the company does not invest in new hardware. Additionally, it is suggested that SaaS is convenient to update, implement, and contains a variety of applications including auditing functions, email services, and customer relationship management (CRM). Expense management software as a service (SaaS) automates all aspects of expense management, including expense analysis, expense reporting, travel booking, employee reimbursement, and other.  Get Free Sample link @ https://www.omrglobal.com/request-sample/saas-based-expense-management-market The growth of the global SaaS-based expense management market is largely driven by the increasing number of technical developments in different industries around the globe and the overall digital revolution. Digital economic development ... Continue reading →

The global antihistamine drugs market is anticipated to grow at a CAGR of 8.7% during the forecast period. The rising prevalence of allergies across the globe is a major factor driving the growth of the antihistamine drug market. The rising healthcare expenditure due to increasing disposable income levels and initiatives by public and private organizations towards spreading awareness related to the treatment of various allergic reactions will further expand the antihistamine drugs market during the forecast period. Antihistamines drugs work well to relieve symptoms of different types of allergies, including seasonal (hay fever), perennial allergic rhinitis, and indoor and food allergies. The drug is also found its effective applications in the treatment of a variety of other conditions such as stomach problems, colds, anxiety, and more.  Get Free Sample link @ https://www.omrglobal.com/request-sample/antihistamine-drugs-market The antihistamine drugs market growth is also ... Continue reading →

The global beauty tools market is anticipated to grow at a CAGR of 10.3% during the forecast period. The major factors that are contributing to the growth of the global beauty tools market include the rising inclination toward the physical appearance to look younger and attractive, and rising awareness about personal grooming is propelling product demand. The product manufacturers promote their brands and innovative technologies through social media campaigns. Moreover, increased investments in celebrity endorsement by beauty tool manufacturers to influence the target customers will further likely create new prospects in terms of product demand. The market growth is mainly attributed to the significant investment by the women population across the globe in beauty products and tools.  As per Groupon’s study in 2020, women spend an average of $3,756 a year (or $313 a month), which adds up to $225,360 throughout their entire lifetime (ages 18-78). The demand for beauty ... Continue reading →

The global tuberculosis vaccine market is anticipated to grow at a CAGR of 8.4% during the forecast period. Tuberculosis vaccine such as BCG (stands for Bacille Calmette-Guérin) is the most widely used tuberculosis vaccine and are being commercialized for the prevention of tuberculosis. Various advancements in the areas of mycobacterial immunology and genomics have fueled the research on multiple new experimental vaccines that is the key factor driving the market growth. In addition to this, the relatively low cost of these vaccines, as well as the easy availability of the vaccine are the major drivers of the industry growth. With an increase in the number of tuberculosis cases globally, the demand for tuberculosis vaccines is projected to increase more, thereby driving the market growth. As per WHO, a total of 1.5 million people died from TB in 2020 (including 214 000 people with HIV). In the same year, 1.1 million children fell ill with TB globally. TB is the 13th leading ... Continue reading →

The global favipiravir market is anticipated to grow at a CAGR of 4.1% during the forecast period. Favipiravir is a broad-spectrum antiviral that has shown promise in the treatment of influenza virus infections, Ebola, COVID-19, and others. With the surging prevalence of such diseases, the demand for favipiravir is also growing at an alarming rate, thereby driving the market growth. As per the Centers for Disease Control and Prevention estimates, there were 9 million – 41 million illnesses, 140,000 – 710,000 hospitalizations, and 12,000 – 52,000 mortality reported in 2020 due to influenza virus infections. Furthermore, the usage of favipiravir drugs in the treatment of COVID-19 is also expected to create new growth opportunities. However, clinical trials are going on in the US, Italy, and Japan and as of now, it is believed that the drug could come out as a potential treatment for COVID-19. As favipiravir possesses high utility for treating patients with COVID-19. ... Continue reading →

The global tuberculosis vaccine market is anticipated to grow at a CAGR of 8.4% during the forecast period. Tuberculosis vaccine such as BCG (stands for Bacille Calmette-Guérin) is the most widely used tuberculosis vaccine and are being commercialized for the prevention of tuberculosis. Various advancements in the areas of mycobacterial immunology and genomics have fueled the research on multiple new experimental vaccines that is the key factor driving the market growth. In addition to this, the relatively low cost of these vaccines, as well as the easy availability of the vaccine are the major drivers of the industry growth. With an increase in the number of tuberculosis cases globally, the demand for tuberculosis vaccines is projected to increase more, thereby driving the market growth. As per WHO, a total of 1.5 million people died from TB in 2020 (including 214 000 people with HIV). In the same year, 1.1 million children fell ill with TB globally. TB is the 13th leading ... Continue reading →

The global anti-viral drug market is anticipated to grow at a CAGR of 4.0% during the forecast period. The growing prevalence of numerous infectious diseases such as HIV, Hepatitis, Herpes Virus, COVID-19, Ebola, and seasonal influenza globally is one of the major factors increasing the demand for anti-viral drugs. In 2019, an estimated 1.2 million people in the US aged 13 and older had HIV, as per HIV.gov estimates. The demand for anti-viral drugs has surged since the time of the COVID-19 pandemic. Many organizations had been working towards the development of anti-viral drugs and therapeutics for COVID-19 at the time of the pandemic, which leads to the high drug development and that has further affected the market positively. For instance, in 2020, NIAID partnering NIH Institutes and initiated an intensive research program to prioritize and accelerate the development of COVID-19 therapeutics. The research program was enhanced through the APP’s discovery and development ... Continue reading →

The global AI in genomics market is anticipated to grow at a significant CAGR of 50.2% during the forecast period (2024-2031). Several advances conducted in the field of pharmaceutical and artificial intelligence (AI) which is likely to boost the growth of the global AI in the genomics market. For instance, in November 2020, Dell Technologies announced new Dell EMC Ready Solutions and high-performance computing(HPC), cloud service provider collaboration to accelerate AI and advanced computing innovation in healthcare, life science, and manufacturing. Moreover, it is specifically designed for bioinformatics and workload management that provides assistance to process complex genomics data faster for personalized treatment of diseases. Moreover, in March 2022, Fabric Genomics Inc. unveiled that the Broad Insitute of MIT and Harvard has selected the company to support the development and implantation of its clinical whole genome sequencing-based offerings. Under the agreement, ... Continue reading →

The global bioprocess technology market is expected to grow at a significant CAGR of 8.2% during the forecast period.  The growing competition in the biotechnology and biopharmaceutical industry coupled with the rising demand for innovative therapeutics owing to the rising prevalence of chronic diseases has led to increasing demand for bioprocess technology. Investment in the biopharmaceuticals industry coupled with the rising need for drugs and vaccines has propelled the market growth. For instance, according to CCI India, India is one of the major producers of generic drugs globally, and the pharmaceutical sector supplies over 50% of global demand for various vaccines, 40% of generic demand in the US, and 25% of all medicines in the UK.   Get Free Sample link @ https://www.omrglobal.com/request-sample/bioprocess-technology-market The key players are continuously focusing on the adoption of various strategic moves such as partnerships, new product launches, ... Continue reading →